Search

Background: Cancer‐targeted T‐cell receptor T (TCR‐T) cells hold promise in treating cancers such as hematological malignancies and breast cancers. However, approaches to obtain cancer‐reactive TCR‐T cells have been unsuccessful. Methods: Here, we developed a novel strategy to screen for cancer‐targeted TCR‐T cells using a special humanized mouse model with person‐specific immune fingerprints. Rare steady‐state circulating hematopoietic stem and progenitor cells were expanded via three‐dimensional culture of steady‐state peripheral blood mononuclear cells, and then the expanded cells were applied to establish humanized mice. The human immune system was evaluated according to the kinetics of dendritic cells, monocytes, T‐cell subsets, and cytokines. To fully stimulate the immune response and to obtain B‐cell precursor NAML‐6‐ and triple‐negative breast cancer MDA‐MB‐231‐targeted TCR‐T cells, we used the inactivated cells above to treat humanized mice twice a day every 7 days. Then, human T cells were processed for TCR β‐chain (TRB) sequencing analysis. After the repertoires had been constructed, features such as the fraction, diversity, and immune signature were investigated. Results: The results demonstrated an increase in diversity and clonality of T cells after treatment. The preferential usage and features of TRBV, TRBJ, and the V–J combination were also changed. The stress also induced highly clonal expansion. Tumor burden and survival analysis demonstrated that stress induction could significantly inhibit the growth of subsequently transfused live tumor cells and prolong the survival of the humanized mice. Conclusions: We constructed a personalized humanized mouse model to screen cancer‐targeted TCR‐T pools. Our platform provides an effective source of cancer‐targeted TCR‐T cells and allows for the design of patient‐specific engineered T cells. It therefore has the potential to greatly benefit cancer treatment. [ABSTRACT FROM AUTHOR]

Copyright of Agronomy Journal is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

The Co‐modified CeO2‐TiO2 catalyst prepared by facile co‐precipitation was used for efficient elemental mercury oxidation in flue gas. Results indicated that Co doping greatly enhanced the activity and SO2 resistance of the CeO2‐TiO2 catalyst. In the presence of 5% O2, 500 ppm NO, 800 ppm SO2 and 3% H2O at 200 °C, the Hg0 removal efficiency of CeCo3/Ti could maintain at about 87% for a relatively long time. Characterizations of catalysts (BET, XRD, Raman spectroscopy, TEM, H2‐TPR, O2‐TPD, XPS, TG‐MS and SO2‐DRIFTS) were carried out to reveal the mechanism of Co modification on the redox ability, SO2 resistance and resultant mercury oxidation removal performance of catalyst. It was found that an interaction of Ce with Co promoted the dispersion of CeO2, increased chemisorbed oxygen concentration, and improved the oxygen storage capacity and the reducibility of catalyst, which was beneficial to the improvement of Hg0 oxidation removal. Hg0 would adsorb onto the catalyst and react with surface active oxygen species replenished by gas‐phase O2 to be oxidized via Mars‐Maessen mechanism. SO2 consumed the surface active oxygen species and resulted in the reduction of Ce4+ to Ce3+, which induced the deactivation of catalyst. The introduced Co in CeO2‐TiO2 catalyst exerted the function of protecting Ce4+ from being poisoned by SO2 and thus promoted the sulfur resistance and Hg0 removal performance of the catalyst in the presence of SO2. [ABSTRACT FROM AUTHOR]